Cancer classification using the Immunoscore: a worldwide task force - Archive ouverte HAL Access content directly
Journal Articles Journal of Translational Medicine Year : 2012

Cancer classification using the Immunoscore: a worldwide task force

(1, 2, 3, 4) , (1, 2, 3) , (4, 5) , (1, 2) , (6) , (7) , (7) , (3) , (8) , (9) , (9) , (10) , (9) , (11) , (12) , (13) , (14) , (15) , (16) , (17) , (18) , (19) , (9) , (20) , (10) , (21) , (22) , (23) , (24) , (9) , (25) , (26) , (26) , (26) , (27) , (28) , (29) , (5) , (30) , (31) , (32) , (33) , (34) , (35) , (36) , (37) , (38) , (39) , (40) , (41) , (9) , (42) , (43) , (43) , (44) , (45) , (46) , (47) , (48) , (49) , (50) , (4, 51) , (52, 53) , (4, 54, 55)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
Magdalena Thurin
  • Function : Author
  • PersonId : 899090
Alessandro Lugli
  • Function : Author
  • PersonId : 935875
Inti Zlobec
  • Function : Author
  • PersonId : 935876
Anne Berger
  • Function : Author
  • PersonId : 935877
Carlo Bifulco
  • Function : Author
  • PersonId : 935878
Gerardo Botti
  • Function : Author
  • PersonId : 935879
Fabiana Tatangelo
  • Function : Author
  • PersonId : 935880
Sebastian Kreiter
  • Function : Author
  • PersonId : 935882
Paolo Delrio
  • Function : Author
  • PersonId : 935884
Hartmann Arndt
  • Function : Author
  • PersonId : 935885
Martin Asslaber
  • Function : Author
  • PersonId : 935886
Michele Maio
  • Function : Author
  • PersonId : 899117
Giuseppe Masucci
  • Function : Author
  • PersonId : 899119
Martin Mihm
  • Function : Author
  • PersonId : 935887
James Allison
  • Function : Author
  • PersonId : 924457
Sacha Gnjatic
  • Function : Author
  • PersonId : 935889
Leif Hakansson
  • Function : Author
  • PersonId : 924481
Harpreet Singh-Jasuja
  • Function : Author
  • PersonId : 924524
Christian Ottensmeier
  • Function : Author
  • PersonId : 935890
Heinz Zwierzina
  • Function : Author
  • PersonId : 924535
Fabio Grizzi
  • Function : Author
  • PersonId : 935892
Patricia Shaw
  • Function : Author
  • PersonId : 935893
Blaise Clarke
  • Function : Author
  • PersonId : 935894
Bradly Wouters
  • Function : Author
  • PersonId : 935895
Yutaka Kawakami
  • Function : Author
  • PersonId : 935896
Kiyotaka Okuno
  • Function : Author
  • PersonId : 935898
Jill O'Donnell-Tormey
  • Function : Author
  • PersonId : 924509
Christine Lagorce
  • Function : Author
  • PersonId : 935899
Graham Pawelec
  • Function : Author
  • PersonId : 914407
Michael Nishimura
  • Function : Author
  • PersonId : 924507
Robert Hawkins
  • Function : Author
  • PersonId : 935900
Shuji Ogino
  • Function : Author
  • PersonId : 935902
Peter Gibbs
  • Function : Author
  • PersonId : 935903
Paul Waring
  • Function : Author
  • PersonId : 935904
Noriyuki Sato
  • Function : Author
  • PersonId : 899129
Toshihiko Torigoe
  • Function : Author
  • PersonId : 935905
Kyogo Itoh
  • Function : Author
  • PersonId : 935906
Prabhu Patel
  • Function : Author
  • PersonId : 935907
Shilin Shukla
  • Function : Author
  • PersonId : 935908
Richard Palmqvist
  • Function : Author
  • PersonId : 935909
Yili Wang
  • Function : Author
  • PersonId : 935911
Corrado d'Arrigo
  • Function : Author
  • PersonId : 935912
Scott Kopetz
  • Function : Author
  • PersonId : 935913
Frank Sinicrope
  • Function : Author
  • PersonId : 935914
Giorgio Trinchieri
  • Function : Author
  • PersonId : 919512

Abstract

Prediction of clinical outcome in cancer is usually achieved by histopathological evaluation of tissue samples obtained during surgical resection of the primary tumor. Traditional tumor staging (AJCC/UICC-TNM classification) summarizes data on tumor burden (T), presence of cancer cells in draining and regional lymph nodes (N) and evidence for metastases (M). However, it is now recognized that clinical outcome can significantly vary among patients within the same stage. The current classification provides limited prognostic information, and does not predict response to therapy. Recent literature has alluded to the importance of the host immune system in controlling tumor progression. Thus, evidence supports the notion to include immunological biomarkers, implemented as a tool for the prediction of prognosis and response to therapy. Accumulating data, collected from large cohorts of human cancers, has demonstrated the impact of immune-classification, which has a prognostic value that may add to the significance of the AJCC/UICC TNM-classification. It is therefore imperative to begin to incorporate the 'Immunoscore' into traditional classification, thus providing an essential prognostic and potentially predictive tool. Introduction of this parameter as a biomarker to classify cancers, as part of routine diagnostic and prognostic assessment of tumors, will facilitate clinical decision-making including rational stratification of patient treatment. Equally, the inherent complexity of quantitative immunohistochemistry, in conjunction with protocol variation across laboratories, analysis of different immune cell types, inconsistent region selection criteria, and variable ways to quantify immune infiltration, all underline the urgent requirement to reach assay harmonization. In an effort to promote the Immunoscore in routine clinical settings, an international task force was initiated. This review represents a follow-up of the announcement of this initiative, and of the J Transl Med. editorial from January 2012. Immunophenotyping of tumors may provide crucial novel prognostic information. The results of this international validation may result in the implementation of the Immunoscore as a new component for the classification of cancer, designated TNM-I (TNM-Immune).
Fichier principal
Vignette du fichier
1479-5876-10-205.pdf (457.88 Ko) Télécharger le fichier
Vignette du fichier
1479-5876-10-205.xml (83.25 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Format : Other
Loading...

Dates and versions

inserm-00780742 , version 1 (24-01-2013)

Identifiers

Cite

Jérôme Galon, Franck Pagès, Francesco Marincola, Helen Angell, Magdalena Thurin, et al.. Cancer classification using the Immunoscore: a worldwide task force. Journal of Translational Medicine, 2012, 10 (1), pp.205. ⟨10.1186/1479-5876-10-205⟩. ⟨inserm-00780742⟩
521 View
774 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More